High 10-year survival rate in patients with early, untreated prostatic cancer.

OBJECTIVE To learn about the natural history of untreated, early-stage prostatic cancer. DESIGN Cohort study with a mean follow-up of 123 months (range, 81 to 165 months). SETTING Population-based, regionally well defined. PATIENTS A consecutive sample of 223 patients (98% of all eligible) with early-stage (T0-2, NX, M0), initially untreated prostatic cancer. MAIN OUTCOME MEASURES Progression-free, disease-specific, and overall survival. Need for palliative and terminal care. INTERVENTION Patients with tumor progression were hormonally treated (orchiectomy or estrogens) if they had symptoms. RESULTS After complete follow-up, only 19 (8.5%) of the 223 patients had died of prostate cancer and 105 (85%) of a total of 124 deaths were from other causes. The 10-year, disease-specific survival rate was 86.8% (95% confidence interval, 80.7% to 92.9%) and was equally high (87.9%) in a subgroup of 58 patients who met current indications for radical prostatectomy. The progression-free, 10-year survival rate was 53.1% (95% confidence interval, 44.2% to 62.0%). In 50 of 76 patients, local growth provided the only evidence of progression, and endocrine treatment was generally successful in these cases. Following an initial increase, the rate of disease progression and death from prostate cancer decreased during the last years of follow-up. CONCLUSION The low disease-specific mortality rate, especially in patients with highly and moderately differentiated tumors, means that any local or systemic therapy intended for patients with early prostatic cancer must be evaluated in clinical trials with untreated controls for comparison.

[1]  I. Thompson,et al.  Expectant management of localized prostatic cancer , 1991, Cancer.

[2]  B. Gustafsson,et al.  Diagnosis and localization of prostate carcinoma by fine-needle aspiration cytology and correlation with histologic whole-organ sections after radical prostatectomy. , 1990, American journal of clinical pathology.

[3]  R. Middleton,et al.  Selection of patients with stage B prostate cancer for radical prostatectomy. , 1990, The Urologic clinics of North America.

[4]  P. Scardino Early detection of prostate cancer. , 1989, The Urologic clinics of North America.

[5]  P. Scardino,et al.  Prognostic significance of lymph nodal metastases in prostate cancer. , 1989, The Journal of urology.

[6]  H. Adami,et al.  NATURAL HISTORY OF LOCALISED PROSTATIC CANCER A Population-based Study in 223 Untreated Patients , 1989, The Lancet.

[7]  R. Gibbons,et al.  Total prostatectomy for clinically localized prostatic cancer: long-term results. , 1989, The Journal of urology.

[8]  P. H. Powell,et al.  Deferred treatment for prostate cancer. , 1988, British journal of urology.

[9]  N. George NATURAL HISTORY OF LOCALISED PROSTATIC CANCER MANAGED BY CONSERVATIVE THERAPY ALONE , 1988, The Lancet.

[10]  M. Bagshaw Potential for radiotherapy alone in prostatic cancer , 1985, Cancer.

[11]  T. Hakulinen On long-term relative survival rates. , 1977, Journal of chronic diseases.

[12]  G. Murphy,et al.  Chemotherapy of advanced prostatic cancer. Evaluation of response parameters. , 1976, Urology.

[13]  W. Taylor,et al.  Carcinoma of the prostate: a 15-year followup. , 1972, The Journal of urology.

[14]  J. Murphy,et al.  Prognosis in patients with carcinoma of the prostate , 1970, Cancer.

[15]  F. Ederer,et al.  The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.

[16]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.

[17]  T. Gasser,et al.  Treatment of localized prostatic cancer. Radical prostatectomy versus placebo. A 15-year follow-up. , 1988, Scandinavian journal of urology and nephrology. Supplementum.

[18]  Dan Richter Levin,et al.  Cancer of the prostate: is there a need for aggressive treatment? , 1987, Urologia internationalis.

[19]  P. Esposti Cytologic malignancy grading of prostatic carcinoma by transrectal aspiration biopsy. A five-year follow-up study of 469 hormone-treated patients. , 1971, Scandinavian journal of urology and nephrology.

[20]  D. Karnofsky The clinical evaluation of chemotherapeutic agents in cancer , 1949 .